Correlation Between Atreca and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Atreca and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atreca and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atreca Inc and Akero Therapeutics, you can compare the effects of market volatilities on Atreca and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atreca with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atreca and Akero Therapeutics.
Diversification Opportunities for Atreca and Akero Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Atreca and Akero is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Atreca Inc and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Atreca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atreca Inc are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Atreca i.e., Atreca and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Atreca and Akero Therapeutics
If you would invest 2,661 in Akero Therapeutics on November 8, 2024 and sell it today you would earn a total of 3,095 from holding Akero Therapeutics or generate 116.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Atreca Inc vs. Akero Therapeutics
Performance |
| Timeline |
| Atreca Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Akero Therapeutics |
Atreca and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Atreca and Akero Therapeutics
The main advantage of trading using opposite Atreca and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atreca position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Atreca vs. Passage Bio | Atreca vs. Stoke Therapeutics | Atreca vs. Revolution Medicines | Atreca vs. Black Diamond Therapeutics |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |